June 1, 2021, 3:58 PM

Adar Poonawalla, CEO, Serum Institute of India

Adar Poonawalla, CEO, Serum Institute of India

A man in Uttar Pradesh's Lucknow has filed a complained against Serum Institute of India (SII) CEO Adar Poonawalla and others while alleging that he did not develop antibodies despite taking a dose of Covishield, which is manufactured by SII. The man has also alleged that his platelet count went down and he became more prone to COVID after taking first dose of Covishield.

The man Pratap Chandra, in his complaint filed at Aashiana Police Station in Lucknow, has also named Luv Agrawal (Joint Secretary, Union Health Ministry), Dr Balram Bhargava (Director, ICMR), Aparna Upadhyay (Director, National Health Mission) and others on his complaint.

As per Chandra, he received the first dose of Covishield on April 8. He was supposed to take the second dose 28 days but the government extended the gap between two doses to six weeks. Later the government again extended the gap between two doses by 12 weeks.

Chandra said that as ICMR director said through press briefings that good amount of antibodies develop after first dose of Covishield, he went for COVID antibody test at a government-approved lab. The results revealed that Chandra not developed antibodies against COVID. Chandra alleged that his platelet count went down to 1.5 lakh from 3 lakh making him more prone to COVID.

The police have received the complaint but have not filed any FIR in the case. However, the police said that top officials have informed about the complaint for further course of action. 

To Comment please login Add Comment
logo

Latest Articles